ezetimibe has been researched along with pyruvic acid in 2 studies
Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (pyruvic acid) | Trials (pyruvic acid) | Recent Studies (post-2010) (pyruvic acid) |
---|---|---|---|---|---|
2,484 | 563 | 1,465 | 8,310 | 169 | 2,501 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishii, H; Kawakami, A; Nomura, M; Yoshida, M | 1 |
Kashiwagi, A; Kume, S; Maegawa, H; Maeno, Y; Morino, K; Nagai, Y; Nishio, Y; Sekine, O; Ugi, S; Ushio, M; Yoshizaki, T | 1 |
2 other study(ies) available for ezetimibe and pyruvic acid
Article | Year |
---|---|
Inhibition of hepatic Niemann-Pick C1-like 1 improves hepatic insulin resistance.
Topics: Animals; Anticholesteremic Agents; Azetidines; Blotting, Western; Cells, Cultured; Cholesterol; DNA Primers; Endoplasmic Reticulum; Ezetimibe; Fatty Liver; Glucose; Glucose Tolerance Test; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; Membrane Transport Proteins; Pyruvic Acid; Rats; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; RNA Interference; RNA, Messenger; Superoxides; Triglycerides | 2009 |
Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet.
Topics: Animals; Anticholesteremic Agents; Apolipoproteins B; Azetidines; Azo Compounds; Blotting, Western; Cell Nucleus; Diet; Diet, High-Fat; Electrophoretic Mobility Shift Assay; Enterocytes; Ezetimibe; Fatty Liver; Fructose; Glucose Tolerance Test; Intestinal Mucosa; Intestines; Lipid Metabolism; Lipoproteins; Liver; Male; Mice; Mice, Inbred CBA; Pyruvic Acid; Real-Time Polymerase Chain Reaction; RNA | 2013 |